The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Pembrolizumab Therapy for Microsatellite Instability-High Colorectal Cancer

Luis A. Diaz Jr., MD
Published Online:4:49 PM, Wed June 14, 2017

Luis A. Diaz Jr., MD, head, Division of Solid Tumor Oncology, discusses pembrolizumab (Keytruda) therapy for microsatellite instability-high colorectal cancer and other tumor types.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.